Quantcast Cancer News
Cancer News By sherri.place
Web | Images | News
News HomeUSWorldBusinessFinanceIndustryTechnologyScienceMedia & AdvertisingPolitics/LawEntertainmentInternetHealthSportsCulture
Cancer News >> PHARMACEUTICAL INDUSTRY November 19, 2008 members login here
Participate
Build a News Circle
Receive News Briefings
Add this Circle to favorites
Share this News Circle
Subscribe to this News Circle
>>  PHARMACEUTICAL INDUSTRY
UPDATE 2-Double Zactima, Pulmicort blow for AstraZeneca
Reuters - 5 Hours ago
* Mixed results in late-stage Zactima trial * Rival Teva gets approval for generic form of Pulmicort * Shares fall 4.6 pct (Adds share price, analyst reaction) LONDON, Nov 19 (Reuters) - Anglo-Swedish
AstraZeneca suffers Pulmicort reverse City A.M.
UPDATE: Astrazeneca Falls On FDA Nod For Generic Pulmicort Wall Street Journal Online
all 21 news articles >>      Add Comment

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in
Houston Chronicle - 5 Hours ago
-Triggers $5 Million Payment from Roche- MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (MEMY) today announced that it has achieved the enrollment goal for its Phase 2
Memory Pharmaceuticals (MEMY) Achieves Enrollment Goal for Phase 2 Trial of MEM Street Insider
Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study PR Newswire via MSN Money
all 2 news articles >>      Add Comment

BRIEF-Sciclone secures $6 mln in debt financing
Forbes.com - 4 Hours ago
Nov 19 (Reuters) - Sciclone Pharmaceuticals Inc: * Secures $6 million in debt financing from silicon valley bank * Says bank line will be used to provide additional working capital (For more news, please
SciClone Pharma secures $6 Mln Debt Financing From Silicon Valley Bank - Quick Facts RTTNews.com
SciClone Secures $6 Million in Debt Financing From Silicon Valley Market Wire via MSN Money
all 4 news articles >>      Add Comment

Elixir Pharmaceuticals' Phase III Trial of Metformin-Mitiglinide Combination Therapy...
Forbes.com - 3 Hours ago
'These positive results from our study provide additional clinical evidence supporting the benefits of Metgluna therapy in the treatment of type 2 diabetes. Metgluna, a one-tablet, fixed combination therapy
Elixir Pharmaceuticals Phase III Trial of Metformin-MitiglinideCombination Therapy Genetic Engineering News
Elixir Pharmaceuticals' Phase III Trial of Metformin-Mitiglinide Combination Therapy Calibre Macro World
all 5 news articles >>      Add Comment

UPDATE 2-Sanofi allows Allegra, Nasacort copies in U.S.
Forbes.com - 5 Hours ago
PARIS, Nov 19 (Reuters) - French drugmaker Sanofi-Aventis (nyse: SNY - news - people ) on Wednesday agreed to allow the sale of generic copies of certain versions of allergy drugs Allegra and Nasacort
2nd UPDATE: Sanofi Settles Some US Allegra Patent Suits Wall Street Journal Online
UPDATE: Sanofi Settles Some Allegra, Nasacort Patent Suits Wall Street Journal Online
all 8 news articles >>      Add Comment

MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
MarketWatch - 4 Hours ago
/PRNewswire-FirstCall via COMTEX/ -- Company prepares to launch Moxatag(TM), the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009 MiddleBrook Pharmaceuticals, Inc. (MBRK:
     Add Comment

Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
Forbes.com - 4 Hours ago
'The acquisition of V-Clip is indicative of our confidence in the value of its now proven research model, the development of which was led by Dr. M. Karen Newell, who we believe is on the cutting edge
Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals,Inc. Pharma Live
all 1 news articles >>      Add Comment

Teva, Barr settle patent dispute with Sanofi
CNBC - 4 Hours ago
NEW YORK - Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc. settled a patent lawsuit with Sanofi-Aventis' over allergy drugs Allegra and Nasacort, allowing sales of certain generic doses
AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Pharma Live
BRIEF-Albany announces agreement with Teva and Barr to settle litigation 12 mins CNBC
all 6 news articles >>      Add Comment

Sanofi-Aventis settles patent infringement cases
CNBC - 2 Hours ago
PARIS - Sanofi-Aventis SA said Wednesday it has settled lawsuits against rival drugmakers it accused of infringing on its patents in the United States with their generic versions of its allergy treatments
     Add Comment

Bovie Medical Corporation Announces FDA 510(K) Clearance to Market SEER Tissue Resection
Forbes.com - 4 Hours ago
HomeBusiness Tech Markets Entrepreneurs Leadership Personal Finance ForbesLife Lists Opinions Video Blogs E-mail Newsletters People Tracker Portfolio Tracker Special Reports Commerce Energy Health Care
Bovie Medical Corporation Announces FDA 510(K) Clearance to MarketSEER Tissue Resection Genetic Engineering News
Bovie Medical Corporation Announces Closing of $4 Million Industrial Revenue Bond PR inside
all 4 news articles >>      Add Comment

Research and Markets: Hungary Pharmaceuticals and Healthcare Report Q4 2008 Report
Forbes.com - 110 Minutes ago
Hungary Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Hungary's pharmaceuticals and healthcare industry. In our new Business Environment Rankings
     Add Comment

U.S. food, drug regulator opens first overseas office in Beijing
Xinhua News Agency - 112 Minutes ago
BEIJING, Nov. 19 (Xinhua) -- The U.S. Food and Drug Administration (FDA) opened its first overseas office here on Wednesday. The office will mainly be responsible for communicating with relevant regulatory
China food, drug inspection transparency improving: FDA (ABC) Yahoo! News Australia
China food, drug inspection transparency improving: FDA Yahoo! News Australia
all 10 news articles >>      Add Comment

Seven Investigator-Initiated Clinical Studies Announced
Forbes.com - 4 Hours ago
All seven studies are investigator-initiated and to be performed under local and country guidelines. Cytori, who will not sponsor these studies, will continue work with country authorities, such as the
Daiichi Sankyo initiates clinical studies of anti-influenza drug TradingMarkets
Daiichi Sankyo & Biota start Phase III Asian trials for next generation Relenza BioPortfolio
all 2 news articles >>      Add Comment

Savient Pharma CEO resigns; names new President; Forms BLA Oversight Committee for
RTTNews.com - 3 Hours ago
Savient Pharmaceuticals, Inc. (SVNT: News ) announced the appointment of Paul Hamelin as president, following the resignation of the company's president, chief executive officer and director, Christopher
Savient Pharma Names Paul Hamelin President, Philip Yachmetz SVP; Constitutes BLA RTTNews.com
all 1 news articles >>      Add Comment

PDL BioPharma sets Dec. 3 as record date for spin-off of biotechnology operations
RTTNews.com - 50 Minutes ago
PDL BioPharma, Inc (PDLI: News ) said that its board has set December 3 as the record date for the spin-off of its biotechnology operations, which will be carried out through a pro rata stock dividend
     Add Comment

GlaxoSmithKline rejected warning
MarketWatch - 70 Minutes ago
LONDON (MarketWatch) -- GlaxoSmithKline (GSK:GSKNews, chart, profile, moreLast: Delayed quote dataAnalyst Create alertInsider Discuss Financials Sponsored by:, , ) (UK:GSK:UK:GSKNews, chart, profile,
     Add Comment

Sanofi Settles Old Scores
Forbes.com - 77 Minutes ago
The drug maker will let rivals sell cheaper versions of its drugs in exchange for royalties. French drug maker Sanofi-Aventis decided on Wednesday to allow competitors to sell generic versions of some
     Add Comment

PDL BioPharma sets Dec. 3 as record date for spin-off of its biotechnology operations
RTTNews.com - 91 Minutes ago
PDL BioPharma, Inc. (PDLI: News ) announced that its board of directors has set December 3, 2008 as the record date for the spin-off of PDL's biotechnology operations, which will be accomplished through
     Add Comment

AstraZeneca Dips In Pre-Market On Results Of Lung Cancer Drug Study
RTTNews.com - 91 Minutes ago
(RTTNews) - AstraZeneca (AZN: News ) slid in pre-market trading, on the results of its phase II study of ZACTIMA on patients with lung cancer. The stock was down $1.55 just before 9:20 am ET, slipping
     Add Comment

Teva gets FDA approval for generic asthma drug
CNBC - 2 Hours ago
NEW YORK - Generic drug developer Teva Pharmaceutical Industries Ltd. said Wednesday the Food and Drug Administration approved its version of AstraZeneca's asthma treatment Pulmicort. Israel-based Teva
     Add Comment

RXi Pharma names Konstantinos Andrikopoulos VP, Legal Counsel and Chief Intellectual
RTTNews.com - 2 Hours ago
US Economic News European Economic News Asian Economic News All Economic News FX Top Stories Currency Alerts Mkt Sensitive News Politics European Mkt Updates Asian Mkt Updates Treasury Mkt Updates Daily
     Add Comment

Glaxo rejected warning
MarketWatch - 4 Hours ago
LONDON (MarketWatch) -- GlaxoSmithKline (GSK:GSKNews, chart, profile, moreLast: Delayed quote dataAnalyst Create alertInsider Discuss Financials Sponsored by:, , ) (UK:GSK:UK:GSKNews, chart, profile,
     Add Comment

Generic version of AstraZeneca asthma drug approved by FDA
MarketWatch - 4 Hours ago
LONDON (MarketWatch) -- Astrazeneca PLC (AZN:AZNNews, chart, profile, moreLast: Delayed quote dataAnalyst Create alertInsider Discuss Financials Sponsored by:, , ) Wednesday said the U.S. Federal Drug
     Add Comment

BRIEF-Sanofi Aventis says signs deal to settle U.S. patent infringement suits related
CNBC - 8 Hours ago
PARIS, Nov 19 (Reuters) - Sanofi-Aventis SA: * Says signs Barr pharmaceuticals and Teva * Says has agreed to grant barr and teva a license to certain patent rights to permit barr and teva to sell certain
Sanofi-Aventis withdraws extension application Bio Spectrum Asia
Sanofi-Aventis Settles Some Allegra,Nasacort Patent Litigations Morningstar.com
all 4 news articles >>      Add Comment

Chelsea Therapeutics Completes Enrollment in Phase II Trial of Droxidopa in Intradialytic
MarketWatch - 4 Hours ago
Top Line Data Expected in First Quarter 2009 CHARLOTTE, N.C., Nov 19, 2008 (GlobeNewswire via COMTEX) -- Chelsea Therapeutics International, Ltd. (CHTP: CHTP News, chart, profile, more Last: Delayed quote
Chelsea Therapeutics Completes Patient Enrollment in Phase II Trial of Droxidopa RTTNews.com
Affymax completes enrolment for phase 3 trial of Hematide for anaemia PharmaBiz
all 14 news articles >>      Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?
Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.